Summit Therapeutics, Inc. (SMMT)
14.16
+0.54
(+3.96%)
USD |
NASDAQ |
Sep 01, 16:00
14.16
0.00 (0.00%)
After-Hours: 16:13
Summit Therapeutics Cash and Short Term Investments (Quarterly) : 691.00M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 691.00M |
| March 31, 2026 | 599.05M |
| December 31, 2025 | 713.76M |
| September 30, 2025 | 238.88M |
| June 30, 2025 | 298.19M |
| March 31, 2025 | 361.63M |
| December 31, 2024 | 412.67M |
| September 30, 2024 | 487.22M |
| June 30, 2024 | 325.79M |
| March 31, 2024 | 157.00M |
| December 31, 2023 | 186.24M |
| September 30, 2023 | 198.94M |
| June 30, 2023 | 215.01M |
| March 31, 2023 | 241.93M |
| December 31, 2022 | 648.61M |
| September 30, 2022 | 121.97M |
| June 30, 2022 | 57.34M |
| March 31, 2022 | 77.45M |
| December 31, 2021 | 71.79M |
| September 30, 2021 | 80.25M |
| June 30, 2021 | 103.39M |
| March 31, 2021 | 102.19M |
| December 31, 2020 | 66.42M |
| September 30, 2020 | 21.27M |
| Date | Value |
|---|---|
| June 30, 2020 | |
| March 31, 2020 | 55.05M |
| January 31, 2020 | |
| October 31, 2019 | |
| July 31, 2019 | |
| April 30, 2019 | |
| January 31, 2019 | 35.33M |
| October 31, 2018 | 16.67M |
| July 31, 2018 | 22.47M |
| April 30, 2018 | 36.99M |
| January 31, 2018 | 28.59M |
| October 31, 2017 | 42.24M |
| July 31, 2017 | 37.30M |
| April 30, 2017 | 25.05M |
| January 31, 2017 | 35.30M |
| October 31, 2016 | 42.28M |
| July 31, 2016 | 9.289M |
| April 30, 2016 | 14.63M |
| January 31, 2016 | 23.13M |
| October 31, 2015 | 34.27M |
| July 31, 2015 | 41.25M |
| April 30, 2015 | 45.20M |
| January 31, 2015 | 16.92M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| NovelStem International Corp. | 0.0562M |
| Brainstorm Cell Therapeutics, Inc. | 0.022M |
| Kezar Life Sciences, Inc. | 66.23M |
| Protara Therapeutics, Inc. | 142.49M |
| Clene, Inc. | 9.671M |